Role of Toll-Like Receptors in Bacterial Keratitis
Toll 样受体在细菌性角膜炎中的作用
基本信息
- 批准号:8206825
- 负责人:
- 金额:$ 36.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesApoptosisApoptoticBacteriaBiological AssayBlindnessCellsClinicalCorneaCorneal DiseasesDNADataDefensinsDevelopmentDinoprostoneDiseaseDisease OutcomeEndotoxinsExtended-Wear Contact LensesEyeGoalsHealedHealthHistopathologyHumanImmune responseInbred BALB C MiceIncidenceInfectionInflammatoryInjection of therapeutic agentInterleukin-1 ReceptorsKeratitisLeukocytesLinkMedical EconomicsMessenger RNAMolecularMolecular ImmunologyMolecular and Cellular BiologyMusNatural ImmunityOrganismPathogenesisPatientsPerforationPeroxidasesPhenotypePlayProcessProductionProtein FamilyPseudomonasPseudomonas aeruginosaRNAReceptor SignalingRecombinant ProteinsRegulationReverse Transcriptase Polymerase Chain ReactionRoleSignal PathwaySignal TransductionStaining methodStainsTLR4 geneTechniquesTestingTimeToll-like receptorsTreatment CostUnited StatesVascular Endothelial Growth FactorsVision researchWestern Blottingabstractingangiogenesisantimicrobial peptidebacterial resistancecaspase-3clinical carecyclooxygenase 2early onseteconomic impacthealinginflammatory modulationinsightkillingsmembermicrobialneutrophilnovelpathogenpreventpro-caspase-3programsresearch studyresponsetoll-like receptor 4
项目摘要
Project Summary/Abstract
Pseudomonas aeruginosa (P. aeruginosa) is a common opportunistic organism
associated with bacterial keratitis, especially in extended wear contact lens users. Our
goal is to determine the molecular mechanisms for development of bacterial keratitis,
specifically, the role of Toll-like receptor (TLR) 4, which at present remains
underexplored in the eye. We hypothesize that TLR4 plays a critical role in the innate
immune response to P. aeruginosa in the cornea and that the activation and signaling
through this TLR will regulate disease outcome. Three specific aims are proposed: 1) To
test the hypothesis that TLR4 regulates inflammatory angiogenesis in the infected
cornea. 2) To test the hypothesis that TLR4 regulates apoptosis in the infected cornea.
3) To test the hypothesis that TLR4 regulates antimicrobial peptides in the infected
cornea. Experiments will include use of techniques such as real time RT-PCR, short
interfering RNA (siRNA), as well as plate counts, enyme linked immunosorbant assay
(ELISA), myeloperoxidase assay (MPO) for neutrophil (PMN) quantitation, dual antibody
immunostaining, histopathology, Tunel assay, DNA laddering, NF¿B functional assays
and Western blotting. Our long-term objective is to understand the interactions between
bacteria and the immune response in the mouse cornea so that non-conventional
therapies against keratitis can be developed for human patients. Since in the United
States alone the incidence of microbial keratitis is 25,000-30,000 cases annually, with
cost of treatment estimated at $15-30 million, and with emerging bacterial resistance, the
studies are of relevance to human health and have considerable medical and economic
impact.
项目摘要/摘要
铜绿假单胞菌是一种常见的机会微生物。
与细菌性角膜炎有关,尤其是长期配戴隐形眼镜的人。我们的
目的是确定细菌性角膜炎发生的分子机制,
具体地说,Toll样受体(TLR)4的作用,目前仍然
在眼睛里没有被充分发掘。我们假设TLR4在先天的
角膜对铜绿假单胞菌的免疫应答及其激活和信号转导
通过这一TLR将调节疾病的结局。提出了三个具体目标:1)
验证TLR4调节感染者炎性血管生成的假说
眼角膜。2)验证TLR4调控感染角膜细胞凋亡的假说。
3)验证TLR4调节感染者体内抗菌肽的假设
眼角膜。实验将包括使用实时RT-PCR、Short
干扰RNA(SiRNA)和平板计数,酶联免疫吸附试验
(ELISA)、髓过氧化物酶(MPO)测定中性粒细胞(PMN)双抗体
免疫组织化学染色、组织病理学、TUNEL法、DNA梯状条带、核因子B功能检测
和Western blotting。我们的长期目标是了解
细菌和小鼠角膜的免疫反应使非常规
可以为人类患者开发治疗角膜炎的方法。因为在美国
仅在美国,每年微生物角膜炎的发病率就有25,000-30,000例,其中
治疗费用估计为1500-3000万美元,随着细菌耐药性的出现,
研究与人类健康相关,并具有相当大的医疗和经济价值
冲击力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA D HAZLETT其他文献
LINDA D HAZLETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA D HAZLETT', 18)}}的其他基金
Airborne Particulates, Corneal Oxidative Stress and Infection
空气中的颗粒物、角膜氧化应激和感染
- 批准号:
10704266 - 财政年份:2023
- 资助金额:
$ 36.12万 - 项目类别:
Role of Toll-Like Receptors in Bacterial Keratitis
Toll 样受体在细菌性角膜炎中的作用
- 批准号:
6989702 - 财政年份:2005
- 资助金额:
$ 36.12万 - 项目类别:
Role of Toll-Like Receptors in Bacterial Keratitis
Toll 样受体在细菌性角膜炎中的作用
- 批准号:
8386603 - 财政年份:2005
- 资助金额:
$ 36.12万 - 项目类别:
Attacking the Global Problem of Antimicrobial Resistance
解决全球抗生素耐药性问题
- 批准号:
10703395 - 财政年份:2005
- 资助金额:
$ 36.12万 - 项目类别:
Attacking the Global Problem of Antimicrobial Resistance
解决全球抗生素耐药性问题
- 批准号:
10477990 - 财政年份:2005
- 资助金额:
$ 36.12万 - 项目类别:
Attacking the Global Problem of Antimicrobial Resistance
解决全球抗生素耐药性问题
- 批准号:
10218181 - 财政年份:2005
- 资助金额:
$ 36.12万 - 项目类别:
Role of Toll-Like Receptors in Bacterial Keratitis
Toll 样受体在细菌性角膜炎中的作用
- 批准号:
6844801 - 财政年份:2005
- 资助金额:
$ 36.12万 - 项目类别:
Role of Toll-Like Receptors in Bacterial Keratitis
Toll 样受体在细菌性角膜炎中的作用
- 批准号:
7569122 - 财政年份:2005
- 资助金额:
$ 36.12万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 36.12万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 36.12万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 36.12万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 36.12万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 36.12万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 36.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 36.12万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 36.12万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 36.12万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 36.12万 - 项目类别: